Clinical Trial Update: Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updating equivalence of a stable liquid glucagon formulation with freshly reconstituted lyophilized glucagon in type 1 diabetes; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• glucagon (lyophilized, reconstituted) (glucagon)
• glucagon (stable liquid formulation) (glucagon)

Snippet

Sponsor: Steven J. Russell, MD, PhD | Conditions: Type 1 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-10-08